H. Lundbeck A/S

(PINK:HLUKF)

Latest On H. Lundbeck A/S (HLUKF):

Date/Time Type Description Signal Details
2023-05-13 23:48 ESTNewsH Lundbeck A/S (HLUKF) Q1 2023 Earnings Call TranscriptN/A
2023-05-13 23:48 ESTNewsH. Lundbeck A/S 2023 Q1 - Results - Earnings Call PresentationN/A
2023-02-09 05:16 ESTNewsH Lundbeck A/S (HLUKF) Q4 2022 Earnings Call TranscriptN/A
2022-11-12 15:37 ESTNewsH Lundbeck A/S (HLUKF) Q3 2022 Earnings Call TranscriptN/A
2022-11-09 17:05 ESTNewsH. Lundbeck A/S Non-GAAP EPS of DKK0.69, revenue of DKK4.72MN/A
2022-08-18 04:24 ESTNewsH Lundbeck A/S (HLUKF) CEO Deborah Dunsire on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-17 11:08 ESTNewsH. Lundbeck A/S GAAP EPS of DKK0.92, revenue of DKK8.84BN/A
2022-06-27 20:25 ESTNewsLundbeck, Otsuka drug helps reduce agitation in Alzheimer’s dementia patients in trialN/A
2022-03-24 06:01 ESTDividendA dividend of $2 has been announced on Feb 9, 2022. It will be paid Mar 28, 2022 with an ex-dividend date of Mar 24, 2022.Neutral
2022-02-10 20:10 ESTNewsH. Lundbeck A/S (HLUKF) CEO Deborah Dunsire on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-10 00:19 ESTNewsH. Lundbeck A/S GAAP EPS of DKK6.63, revenue of DKK16.3BN/A
2021-11-11 17:55 ESTNewsH. Lundbeck A/S 2021 Q3 - Results - Earnings Call PresentationN/A
2021-11-10 21:11 ESTNewsH. Lundbeck A/S reports Q3 resultsN/A
2021-11-10 21:10 ESTNewsH. Lundbeck A/S (HLUKF) CEO Deborah Dunsire on Q3 2021 Results - Earnings Call TranscriptN/A
2021-08-19 19:17 ESTNewsH. Lundbeck A/S (HLUKF) CEO Deborah Dunsire on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-19 19:17 ESTNewsH. Lundbeck A/S 2021 Q2 - Results - Earnings Call PresentationN/A
2021-08-18 22:01 ESTNewsH. Lundbeck A/SN/A
2021-03-24 06:04 ESTDividendA dividend of $2.5 has been announced on Nov 30, -0001. It will be paid Mar 26, 2021 with an ex-dividend date of Mar 24, 2021.Neutral
2021-02-06 05:12 ESTFinancialsCompany financials have been released.Neutral
2021-02-05 19:16 ESTNewsH. Lundbeck A/S (HLUKF) CEO Deborah Dunsire on Q4 2020 Results - Earnings Call TranscriptN/A
2021-02-05 01:25 ESTNewsH. Lundbeck A/S reports FY resultsN/A
2021-02-05 01:25 ESTNewsH. Lundbeck A/S 2020 Q4 - Results - Earnings Call PresentationN/A
2021-01-12 17:12 ESTNewsLundbeck's migraine med OK'd in CanadaN/A
2020-11-26 23:04 ESTFinancialsCompany financials have been released.Neutral
2020-11-10 01:48 ESTNewsH. Lundbeck A/S 2020 Q3 - Results - Earnings Call PresentationN/A
2020-11-08 02:05 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 18:28 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 05:56 ESTFinancialsCompany financials have been released.Neutral
2020-11-06 05:24 ESTFinancialsCompany financials have been released.Neutral
2020-11-04 18:14 ESTNewsH Lundbeck A/S (HLUKF) CEO Deborah Dunsire on Q3 2020 Results - Earnings Call TranscriptN/A
2020-11-03 16:14 ESTNewsH. Lundbeck A/S reports 9M resultsN/A
2020-09-26 15:20 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 07:28 ESTFinancialsCompany financials have been released.Neutral
2020-08-17 06:26 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 11:23 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 08:19 ESTNewsH. Lundbeck A/S reports Q2 resultsN/A
2020-08-14 08:19 ESTNewsH. Lundbeck A/S 2020 Q2 - Results - Earnings Call PresentationN/A
2020-08-14 08:19 ESTNewsH. Lundbeck A/S (HLUKF) CEO Deborah Dunsire on Q2 2020 Results - Earnings Call TranscriptN/A
2020-08-06 14:57 ESTFinancialsCompany financials have been released.Neutral
2020-08-06 10:43 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 19:08 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 07:06 ESTFinancialsCompany financials have been released.Neutral
2020-07-29 23:19 ESTFinancialsCompany financials have been released.Neutral
2020-07-27 14:58 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 19:46 ESTFinancialsCompany financials have been released.Neutral
2020-07-09 11:11 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 18:53 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 02:41 ESTFinancialsCompany financials have been released.Neutral
2020-06-19 14:47 ESTFinancialsCompany financials have been released.Neutral
2020-06-14 06:53 ESTFinancialsCompany financials have been released.Neutral

About H. Lundbeck A/S (HLUKF):

H. Lundbeck A/S engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Onfi for Lennox-Gastaut syndrome; Vyepti for migraine prevention; and Rexulti to treat depression/schizophrenia. It also provides Azilect for treating Parkinson's disease; Cipralex/Lexapro for depression; Ebixa to treat Alzheimer's disease; Sabril for treating epilepsy; and Xenazine for chorea associated with Huntington's disease, as well as other products. The company sells its products primarily to distributors of pharmaceuticals, pharmacies, and hospitals. The company was founded in 1915 and is headquartered in Valby, Denmark.

HLUKF Quotes by TradingView

See Advanced Chart

General

  • Name H. Lundbeck A/S
  • Symbol HLUKF
  • Type Common Stock
  • Exchange PINK
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDrug Manufacturers-Specialty & Generic
  • Full Time Employees 5,628
  • Fiscal Year EndDecember
  • Web URLhttp://www.lundbeck.com
View More

Valuation

  • Trailing PE 11.87
  • Forward PE 20
  • Price/Sales (Trailing 12 Mt.) 2.64
  • Price/Book (Most Recent Quarter) 2.75
  • Enterprise Value Revenue 0.46
  • Enterprise Value EBITDA 1.67
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Profit Margin 9%
  • Return on Assets 5%
  • Return on Equity 9%
  • Earnings Per Share $3.00
  • Revenue Per Share $0
  • Gross Profit 13.55 billion
  • Quarterly Earnings Growth -3.3%
View More

ESG Rating

  • Rating Date 2019-01-01
  • ESG Score 22.22
  • Environment Score 2.92
  • Social Score 9.39
  • Governance Score 5.26
  • Controversy Level 1
View More

Highlights

  • Market Capitalization 6.75 billion
  • PEG Ratio 1.17
  • Book Value Per Share $10.65
View More

Share Statistics

  • Shares Outstanding 198.71 million
  • Shares Float 61.21 million
  • % Held by Insiders <1%
  • % Held by Institutions 80.88%
View More

Technicals

  • Beta 0.56
  • 52 Week High $43.17
  • 52 Week Low $26.25
  • 50 Day Moving Average 38.85
  • 200 Day Moving Average 34.01
View More

Dividends

  • Forward Annual Dividend Rate $0.4
  • Forward Annual Dividend Yield 1.04%
  • Payout Ratio 63%
  • Dividend Date 2012-04-04
  • ExDividend Date 2021-03-24
  • Dividend Per Share $1.25
  • Dividend Yield 0%
View More

H. Lundbeck A/S (HLUKF) Dividend Calendar:

HLUKF's last dividend payment was made to shareholders on April 4, 2012.
H. Lundbeck A/S pays out 63% of its earnings out as a dividend.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

H. Lundbeck A/S (HLUKF) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312020-12-31$4.28 billion$0.45
2020-09-302020-12-31$4.46 billion$0.31
2020-06-302020-09-30$N/A$0.37$1.95-80.82%
2020-03-312020-06-30$4.56 billion$0.44$2.42-81.76%
2019-12-312020-03-31$N/A$0.11$0.57-80.32%
2019-09-302019-12-31$603.67 million-$0.09$4.00-102.36%
2019-06-302019-09-30$642 million$0.55$4.33-87.26%
2019-03-312019-06-30$635.97 million$0.60$4.22-85.7%
2018-12-312019-03-31$644.43 million$0.68$3.30-79.42%
2018-09-302018-12-31$719.4 million$0.51$5.33-90.53%
2018-06-302018-09-30$734.6 million$0.83$4.78-82.71%
2018-03-312018-06-30$757.19 million$0.79$4.52-82.57%
2017-12-312018-03-31$708.19 million$1.00$3.38-70.52%
2017-09-302017-12-31$685.39 million$0.45$3.44-86.96%
2017-06-302017-09-30$4.28 billion$0.70$2.92-76.01%
2017-03-312017-06-30$4.21 billion$0.47$3.05-84.52%
2016-12-312017-03-31$4.17 billion$0.42$1.63-73.96%
2016-09-302016-12-31$0.34$1.23-72.43%
2016-06-302016-09-30$0.24$1.09-77.56%
2016-03-312016-06-30$0.18$1.33-86.79%
2015-12-312016-03-31$0.14$0.73-80.32%
2015-09-302015-12-31-$0.33-$6.8495.17%
2015-06-302015-09-30-$0.96-$0.92-4.11%
2015-03-312015-06-30-$2.97$0.08-3810.38%
2014-12-312015-03-31-$0.06-$2.4097.53%
2014-09-302014-12-31-$0.52-$0.24-118.25%
2014-06-302014-09-30$0.00$0.95-99.55%
2014-03-312014-06-30$0.13
2013-12-312014-03-31$0.31
2013-09-302013-12-31$0.02
2013-06-302013-09-30$0.25
2013-03-312013-06-30-$0.45
2012-12-312013-03-31$0.93
2012-09-302012-12-31$0.18
2012-06-302012-09-30$0.37
2012-03-312012-06-30-$0.07
2011-12-312012-03-31$0.57
2011-09-302011-12-31$0.18
2011-06-302011-09-30$0.32
2011-03-312011-06-30$0.79
2010-12-312011-03-31$0.90
2010-09-302010-12-31$0.22
2010-06-302010-06-30$0.58
2010-03-312010-03-31$0.89
2009-12-312009-12-31$0.24
2009-09-302009-09-30$0.59
2009-06-302009-06-30$0.44
2009-03-312009-03-31$0.62
2008-12-312008-12-31$0.01
2008-09-302008-09-30$0.65
2008-03-312008-03-31$0.63

H. Lundbeck A/S (HLUKF) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

H. Lundbeck A/S (HLUKF) Chart:

H. Lundbeck A/S (HLUKF) News:

Below you will find a list of latest news for H. Lundbeck A/S (HLUKF) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

H. Lundbeck A/S (HLUKF) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

H. Lundbeck A/S (HLUKF) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link